Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 7;17(6):756.
doi: 10.3390/ph17060756.

TRPV1 Channels in the Central Nervous System as Drug Targets

Loris A Chahl  1
Affiliations
Review

TRPV1 Channels in the Central Nervous System as Drug Targets

Loris A Chahl. Pharmaceuticals (Basel). .

Abstract

TRPV1 channels are polymodal cation channels located predominantly on primary afferent neurons that are activated by inflammatory mediators, capsaicin (the active component in chili peppers), and noxious heat. TRPV1 channel antagonists are potential new analgesic agents, but their development has been hindered by the finding that they also produce loss of thermal homeostasis and response to noxious heat. Results from recent studies of the TRPV1 channel indicate that it might be possible to develop TRPV1 channel antagonists that inhibit pain without affecting noxious heat sensation. TRPV1 channels are also present in the central nervous system (CNS) and have been implicated in learning, memory, and behaviour. TRPV1 channel modulators have been proposed to have possible therapeutic potential in the treatment of neurological and psychiatric conditions. However, further understanding of the role of TRPV1 channels in the CNS is required before therapeutic advances in the treatment of neuropsychiatric conditions with TRPV1 channel modulators can be made.

Keywords: CNS; TRPV1; capsaicin; neuropsychiatric disorders; pain; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Koivisto A.-P., Belvisi M.G., Gaudet R., Szallasi A. Advances in TRP channel drug discovery: From target validation to clinical studies. Nat. Rev. Drug Discov. 2022;21:41–59. doi: 10.1038/s41573-021-00268-4. - DOI - PMC - PubMed
    1. Jancsó N., Jancsó-Gábor A., Szolcsányi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmacol. Chemother. 1967;31:138–151. doi: 10.1111/j.1476-5381.1967.tb01984.x. - DOI - PMC - PubMed
    1. Chahl L.A. Antidromic vasodilatation and neurogenic inflammation. Pharmacol. Ther. 1988;37:275–300. doi: 10.1016/0163-7258(88)90029-0. - DOI - PubMed
    1. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature. 1997;389:816–824. doi: 10.1038/39807. - DOI - PubMed
    1. Szolcsányi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides. 2004;38:377–384. doi: 10.1016/j.npep.2004.07.005. - DOI - PubMed

LinkOut - more resources